Activation of adenosine A3 receptors on macrophages inhibits tumor necrosis factor-

European Journal of Pharmacology

Volumn 310, Issue 2-3, 1996, Pages 209-216

  McWhinney, Charlene D ^a,d   Dudley, Mark W ^a   Bowlin, Terry L ^a,e   Peet, Norton P ^a   Schook, Larry ^b   Bradshaw, Marita ^c   De, Mamata ^a   Borcherding, David R ^a   Edwards III, Carl K ^a,f  

^a Merrell Dow Research Institute   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d WEIS CENTER FOR RESEARCH   (United States)

^e Shire Canada   (Canada)

^f AMGEN INC   (United States)

Author keywords

Adenosine A3 receptor; Cross talk; Macrophage; Receptor; TNF (tumor necrosis factor ) inhibition

Indexed keywords

2 CHLORO 6 N CYCLOPENTYLADENOSINE; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 6 N CYCLOPENTYLADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; BW A1433U; CD14 ANTIGEN; MDL 201449A; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ADENOSINE RECEPTOR; HYBRID PROTEIN; LUCIFERASE;

ANIMAL CELL; ARTICLE; BINDING SITE; GENE EXPRESSION; MACROPHAGE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; TUMOR NECROSIS; ANIMAL; CELL LINE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; GENE EXPRESSION REGULATION; GENETICS; MACROPHAGE; METABOLISM; MOUSE;

ANIMALS; CELL LINE; GENE EXPRESSION REGULATION; LUCIFERASES; MACROPHAGES; MICE; RECEPTORS, PURINERGIC P1; RECOMBINANT FUSION PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030605935     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00272-5     Document Type: Article

References (51)

1. Ali, H., J. Cunha-Melo, W. Saul and M. Beaven, 1990, Methylxanthines block antigen-induced responses in RBL-2H3 cells independently of adenosine receptors or cyclic AMP: evidence for inhibition of antigen binding to IgE, J. Biol. Chem. 265(2), 745.
2. 2-adrenergic receptors, Mol. Pharmacol. 38, 348.
3. Bouma, M.G., R.K. Stad, F. Van den Wildenberg and W.A. Burman, 1994. Differential regulatory effects of adenosine on cytokine release by activated human monocytes, J. Immunol. 153, 4159.
4. Cerri, M., A. Beltran-Nunez, S. Bernasconi, E. Dejana, L. Bassi and G. Bazzoni, 1993, Inhibition of cytokine production and endothelial expression of adhesion antigens by 5′-methylthioadenosine, Eur. J. Pharmacol. 232, 291.
5. Chomczynski, P. and N. Sacchi, 1987, A single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochetn. 162, 156.
6. Collart, M., P. Baeuerle and P. Vassali, 1990, Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four κB-like motifs and of constitutive and inducible forms of NF-κB, Mol. Cell. Biol. 10(4), 1498.
7. Collis, M. and S. Hourani, 1993. Adenosine receptor subtypes, TIPS Rev. 14, 360.
8. Daval, J., A. Nehlig and F. Nicholas, 1991, Physiological and pharmacological properties of adenosine; therapeutic implications, Life Sci. 49, 1435.
9. De LaHarpe, J. and C. Nathan, 1989, Adenosine regulates the respiratory burst of cytokine-triggered human neutrophils adherent to biological surfaces, J. Immunol. 143, 596.
10. Delude, R., M. Fenton, R. Savedra, Jr., P. Perera, S. Vogel, R. Thieringer and D. Golenbock, 1994, CD-14 mediated translocation of nuclear factor-κB induced by lipopolysaccharide does not require tyrosine kinase activity, J. Biol. Chem. 269(35), 22253.
11. Drouet, C., A. Shakhov and C. Jongeneel, 1991, Enhancers and transcription factors controlling the inducibility of the TNF-α promoter in primary macrophages. J. Immunol. 147, 1694.
12. Edwards, III, C., L. Watts, M. Parmely, M. Linnik, R. Long and D. Borcherding, 1994, Effect of the carbocyclic nucleoside analogue MDL 20112 on inhibition of interferon-γ-induced priming of Lewis rat macrophages for enhanced respiratory burst and MHC class II IA+ antigen expression, J. Leuk. Biol. 56, 133.
13. Eppell, B., A. Newell and E. Brown, 1989, Adenosine receptors are expressed during differentiation of monocytes to macrophages in vitro, J. Immunol. 143, 4141.
14. Geng, Y., B. Zhang and M. Lotz, 1993, Protein tyrosine kinase activation is required or lipopolysaccharide induction of cytokines in human blood monocytes, J. Immunol. 151, 6692.
15. Han, J., P. Thompson and B. Beutler, 1990, Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway, J. Exp. Med. 172, 391.
16. Heumann, D., P. Gallay, C. Barran, C., P. Zaech, R. Ulevitch, P. Tobias, M. Glauser and J. Baumartner, 1992. Control of lipopolysaccharide and lipopolysaccharide-induced tumor necrosis factor secretion in human blood monocytes, J. Immunol. 148, 3505.
17. 2 cell surface adenosine receptor, Cell. Immunol. 159, 85.
18. 2 receptors in rat brain, J. Pharmacol. Exp. Ther. 251(3), 888.
19. 6-substituted adenosines, J. Med. Chem. 16, 358.
20. 2 receptors on human monocytes modulate C2 production, Clin. Exp. Immunol. 57, 540.
21. LeVraux, V., Y. Chen, I. Masson, M. DeSousa, J. Giroud, I. Florentin and L. Chauvelot-Moachon, 1993, Inhibition of human monocyte TNF production by adenosine receptor agonists, Life Sci. 52, 1971.
22. 3 receptors: pharmacological properties, species differences and receptor functions, TIPS 15, 298.
23. Liu, M., P. Herrera-Velit, R. Brownsey and N. Reiner, 1994, CD-14 dependent activation of protein kinase C and MAP kinases (p42 and p44) in human monocytes treated with bacterial lipopolysaccharide, J. Immunol. 153, 2642.
24. 1 adenosine receptors, Naunyn-Schmiedeberg's Arch. Pharmacol. 337(6), 687.
25. Londos, C., D. Cooper, W. Schlegel and M. Rodbell, 1978, Adenosine analogs inhibit adipocyte adenylate cyclase by a CTP-dependent process: basis for actions of adenosine and methylxanthines on cyclic AMP production and lipolysis, Proc. Natl. Acad. Sci. USA 75, 5362.
26. Londos, C., D. Cooper and J. Wolff, 1980, Subclasses of external adenosine receptors. Proc. Natl. Acad. Sci. USA 77, 2551.
27. 3 receptor, Cancer Res. 54, 3521.
28. Muroi, M. and T. Suzuki, 1993, Role of protein kinase A in lipopolysaccharide-induced activation of NF-KB proteins of a mouse macrophage-like cell line J774, Cell. Signal. 5, 289.
29. Najar, H., S. Ruhl, A. Bru-Capdeville and J. Peters, 1990, Adenosine and its derivatives control human monocyte differentiation into highly accessory cells versus macrophages, J. Leuk. Biol. 47, 429.
30. Naumann, M. and C. Scheidereit, 1994, Activation of NF-kappa B in vivo is regulated by multiple phosphorylations, EMBO J. 13(19), 4597.
31. Parmely, M., W. Zhou, C. Edwards, III, D. Borcherding, R. Silverstein and D. Morrison, 1993, Adenosine and a related carbocyclic nucleoside analogue selectively inhibit Tumor Necrosis Factor-α production and protect mice against endotoxin challenge, J. Immunol. 151, 389.
32. Peacheli, P.T., L.M. Lichtenstein and R.P. Scheimer, 1991, Regulation of human basophil and lung mast cell function by adenosine, J. Pharmacol. Exp. Ther. 256, 717.
33. 3 receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J. Biol. Chem. 268(23), 16887.
34. 2 receptors on rat kupffer cells, Hepatology 19, 1445.
35. 1 adenosine receptor that is widely expressed in brain and spinal cord, Mol. Endocrinol. 5, 1037.
36. Riches, D., J. Watkins, P. Henson and D. Stanworth, 1985, Regulation of macrophage lysosomal secretion by adenosine, adenosine phosphate esters and related structural analogues of adenosine, J. Leuk. Biol. 37, 545.
37. Richter, J., 1992, Effect of adenosine analogues and cAMP raising agents on TNF-, GM-, CSF-and chemotactic peptide-induced degranulation in single adherent neutrophils, J. Leuk. Biol. 51, 270.
38. Salmon, J.E. and B.N. Cronstein, 1990, Fc γ-receptor-mediated functions in neutrophils are modulated by adenosine receptor occupancy, J. Immunol. 145, 2235.
39. 1 receptors, J. Immunol. 151, 2775.
40. 3 receptor, Proc. Natl. Acad. Sci. USA 90, 10365.
41. Sambrook, J., E.F. Fritsch and T. Maniatis, 1989, Molecular Cloning: A Laboratory Manual, 2nd edn. (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY).
42. Schrier, D., M. Lesch, C. Wright and R. Gilbertsen, 1990, The antiinflammatory effects of adenosine receptor agonists on the carrageenan-induced pleural inflammatory response in rats, J. Immunol. 145, 1874.
43. Shakhov, A., M. Collart, P. Vassalli, S. Nedospasov and C. Jongeneel, 1990, KB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the TNF-α gene in primary macrophages, J. Exp. Med. 171, 35.
44. 2 receptor subtype, Mol. Endocrinol. 6, 384.
45. Stiles, G.L., 1992, Adenosine receptors: structure, function and regulation, J. Biol. Chem. 267, 6451.
46. Sullivan, G., J. Linden, E. Hewlett, H. Carper, J. Hylton and G. Mandell, 1990, Adenosine and related compounds counteract tumor necrosis factor-alpha inhibition of neutrophil migration: implication of a novel cyclic AMP-independent action on the cell surface, J. Immunol. 145, 1537.
47. Van Calker, D., M. Muller and B. Hamprecht, 1979, Adenosine regulates via two different receptors the accumulation of cyclic AMP in cultured brain cells, J. Neurochem. 33, 999.
48. 3 receptor, Mol. Pharmacol. 45, 1101.
49. Williams, M., 1984, Adenosine - a selective neuromodulator in the mammalian CNS. Trends Neurosci. 7, 164.
50. Wright, S., R. Ramos, P. Tobias, R. Ulevitch and J. Mathison, 1990, CD14: a receptor for complexes of lipopolysaccharide and lipopolysaccharide binding protein, Science 249, 1431.
51. 3 receptor. Proc. Natl. Acad. Sci. USA 89, 7432.